Norwegian man declared HIV-free after stem cell transplant
Quick Read
Medical experts involved in the case said the man has remained off antiretroviral therapy for an extended period without any viral rebound, a key marker used in determining whether HIV has been effectively eliminated or placed in sustained remission.
A Norwegian man has been declared free of HIV following a stem cell transplant carried out to treat an underlying blood cancer, in what doctors describe as one of the clearest cases yet of long-term remission.
The patient, widely referred to as the “Oslo patient”, received donor stem cells from his brother, whose genetic profile included a rare mutation known to block HIV from entering human cells. The procedure was not intended as a cure for the virus but as treatment for cancer. However, subsequent tests have shown no detectable trace of HIV in his body.
Medical experts involved in the case said the man has remained off antiretroviral therapy for an extended period without any viral rebound, a key marker used in determining whether HIV has been effectively eliminated or placed in sustained remission.
“This represents a significant development in HIV research,” one of the doctors said, noting that the outcome adds to a small but growing list of similar cases worldwide.
Stem cell transplants used in such cases typically rely on donors with a mutation affecting the CCR5 receptor, a pathway HIV commonly uses to infect immune cells. When the patient’s immune system is replaced with donor cells carrying this mutation, the virus is left with no viable route to replicate.
Despite the encouraging outcome, specialists have cautioned against viewing the case as a universal cure. Stem cell transplantation is a complex and high-risk procedure, usually reserved for patients with life-threatening cancers such as leukaemia. It involves destroying the patient’s existing immune system and replacing it with that of a donor, a process that carries significant medical risks.
Researchers say the importance of the Norwegian case lies more in what it reveals about potential pathways to a broader cure. Scientists are studying how similar effects might be achieved through less invasive methods, including gene editing and targeted therapies.
The case adds to fewer than a dozen globally recognised instances in which patients have achieved long-term HIV remission following transplants. While rare, such outcomes continue to shape ongoing efforts to find a scalable and safe cure for the virus.
Comments